Casirivimab and Imdevimab Antibody combination for COVID-19 Prophylaxis Dr. Kamal Kant Kohli30 Nov 2021 7:03 AM GMTCasirivimab and Imdevimab are two non-competing, high-affinity human IgG1 anti-SARS- CoV-2 monoclonal antibodies, which bind specifically to the...
Esomeprazole-prokinetic combination: A novel approach to managing GERD Dr. Shubham Vatsya27 Nov 2021 6:33 AM GMTGastroesophageal reflux disease (GERD) is emerging as a major health concern, having a strikingly high prevalence rate of 7.6% to...
Montelukast - Preferred Choice in Long Term Management of Respiratory Allergies Dr. Kamal Kant Kohli25 Nov 2021 5:50 AM GMTRespiratory Allergies in India - Unique Challenges & Need for Early Interventions An estimated 300 million people worldwide have asthma, with ...
PPIs induced Risk of Recurrent Clostridium difficile Infections and Rationale for Use of Probiotics: Review Dr. Spandan Bhadury23 Nov 2021 3:45 AM GMTClostridium difficile associated diarrhea (CDAD) in India is still an under-recognized etiology of diarrhea. This is largely due to lack of clinical...
Understanding Monogenic Diabetes with Dr V Mohan Dr. V. Mohan17 Nov 2021 6:45 AM GMTWhenever we talk about 'diabetes', we usually mean type 2 diabetes which generally affects adults. Indeed, 90% of all people with diabetes in India...
Combining ARBs, CCBs and Diuretics in controlling Resistant Hypertension in CV patients: Review Dr. Prem Aggarwal12 Nov 2021 7:27 AM GMTA significant increase in resistant hypertension (RH) has been documented in the last decade, with epidemiological data suggesting that the rise has...
Weak cough strength associated with increased extubation failure, finds study Dr Monish Raut10 Nov 2021 6:45 AM GMTThe predictive power of extubation failure diagnosed by cough strength varies by study. Researchers have conducted a meta-analysis to summarise the...
Combatting allergic rhinitis-Why prefer Fexofenadine - Montelukast over Bilastine-Montelukast? dr. Abhimanyu Uppal9 Nov 2021 7:01 AM GMTWith the COVID restrictions getting unlocked in almost all states of India along with the approaching season of allergies, physicians across the...
Improving Diversity in Clinical Trials: The Way Forward Sanjay Vyas7 Nov 2021 10:38 AM GMTHistorically, clinical trials have witnessed under-representation from participants of diverse races and ethnicity due to a variety of factors and...
Antiviral drug Molnupiravir: The next big thing for COVID-19 treatment? Dr. Kamal Kant Kohli29 Oct 2021 4:59 AM GMTNew Delhi: In a major development in the world's battle against the COVID-19 pandemic, an oral drug has shown positive results in reducing both...
Efficacy of Cadexomer Iodine in managing chronic wounds: Reports from a meta-analysis. Dr. Kamal Kant Kohli27 Oct 2021 6:13 AM GMTWound management, especially chronic ones, has been a challenging task for physicians and surgeons. It has been well documented that chronic...
Managing Night Time GERD: Comparative Review of Efficacy of esomeprazole against conventional PPIs Dr. Shubham Vatsya25 Oct 2021 7:15 AM GMTNight-time Gastroesophageal reflux disease (GERD) causing symptoms is now being identified as a distinct clinical entity (1). It is an...
